| Cell line name |
LNY1 |
|---|
| Synonyms |
LNY-1 |
|---|
| Accession |
CVCL_D229 |
|---|
| Resource Identification Initiative |
To cite this cell line use: LNY1 (RRID:CVCL_D229) |
|---|
| Comments |
Population: Japanese. |
|---|
| HLA typing |
Source: PubMed=19818766
| Class I | | HLA-A | A*26,31 | | HLA-B | B*51,54 | | HLA-C | C*04,10 |
|
|---|
| Disease |
Lung adenocarcinoma (NCIt: C3512) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=12060610
Yoshihiko Hirohashi, Toshihiko Torigoe, Akiko Maeda, Yuki Nabeta, Kenjiro Kamiguchi, Takashi Sato, Junichi Yoda, Hideyuki Ikeda, Kouichi Hirata, Noboru Yamanaka, Noriyuki Sato;
An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.
Clin. Cancer Res. 8:1731-1739(2002) PubMed=19818766; DOI=10.1016/j.yexmp.2009.09.021
Yoshihiko Hirohashi, Toshihiko Torigoe, Itaru Hirai, Yasuaki Tamura, Munehide Nakatsugawa, Yuuji Inoue, Takayuki Kanaseki, Kenjiro Kamiguchi, Hideyuki Ikeda, Aya Sasaki, Noboru Yamanaka, Noriyuki Sato;
Establishment of shared antigen reactive cytotoxic T lymphocyte using co-stimulatory molecule introduced autologous cancer cells.
Exp. Mol. Pathol. 88:128-132(2010) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54902864
|
|---|
| Entry history |
|---|
| Entry creation | 22-Oct-2012 |
|---|
| Last entry update | 21-Mar-2023 |
|---|
| Version number | 8 |
|---|
